Wavebreak Therapeutics Limited CAMBRIDGE


Founded in 2016, Wavebreak Therapeutics, classified under reg no. 10054518 is an active company. Currently registered at Clarendon House CB2 8FH, Cambridge the company has been in the business for 8 years. Its financial year was closed on December 31 and its latest financial statement was filed on 2022/12/31. Since 2023/04/12 Wavebreak Therapeutics Limited is no longer carrying the name Wren Therapeutics.

The firm has 6 directors, namely John B., Bart H. and Andrew V. and others. Of them, George M. has been with the company the longest, being appointed on 3 April 2018 and John B. has been with the company for the least time - from 26 July 2023. Currently there are a few former directors listed by the firm. Similarly, the firm lists a few former secretaries. The full list of both former directors and former secretaries might be found in the table below.

Wavebreak Therapeutics Limited Address / Contact

Office Address Clarendon House
Office Address2 Clarendon Road
Town Cambridge
Post code CB2 8FH
Country of origin United Kingdom

Company Information / Profile

Registration Number 10054518
Date of Incorporation Thu, 10th Mar 2016
Industry Other professional, scientific and technical activities not elsewhere classified
End of financial Year 31st December
Company age 8 years old
Account next due date Mon, 30th Sep 2024 (154 days left)
Account last made up date Sat, 31st Dec 2022
Next confirmation statement due date Sat, 23rd Mar 2024 (2024-03-23)
Last confirmation statement dated Thu, 9th Mar 2023

Company staff

John B.

Position: Director

Appointed: 26 July 2023

Bart H.

Position: Director

Appointed: 22 January 2022

Andrew V.

Position: Director

Appointed: 05 November 2019

Fiona D.

Position: Director

Appointed: 29 November 2018

Owen H.

Position: Director

Appointed: 29 November 2018

Pennsec Limited

Position: Corporate Secretary

Appointed: 24 August 2018

George M.

Position: Director

Appointed: 03 April 2018

Patrick C.

Position: Director

Appointed: 16 August 2022

Resigned: 13 January 2023

Tuomas K.

Position: Director

Appointed: 16 August 2022

Resigned: 24 September 2023

Fiona D.

Position: Director

Appointed: 27 April 2018

Resigned: 26 October 2018

Michelle H.

Position: Secretary

Appointed: 11 October 2017

Resigned: 17 August 2018

Adrian H.

Position: Director

Appointed: 29 July 2016

Resigned: 29 October 2018

George M.

Position: Director

Appointed: 29 July 2016

Resigned: 14 March 2018

Michele V.

Position: Director

Appointed: 27 April 2016

Resigned: 12 August 2022

Christopher D.

Position: Director

Appointed: 27 April 2016

Resigned: 08 September 2019

Brian K.

Position: Secretary

Appointed: 01 April 2016

Resigned: 11 October 2017

Samuel C.

Position: Director

Appointed: 01 April 2016

Resigned: 15 August 2022

Alastair K.

Position: Director

Appointed: 10 March 2016

Resigned: 01 April 2016

Alice B.

Position: Director

Appointed: 10 March 2016

Resigned: 01 April 2016

People with significant control

The register of persons with significant control who own or control the company consists of 1 name. As we established, there is Samuel C. The abovementioned PSC and has 25-50% shares.

Samuel C.

Notified on 18 February 2022
Nature of control: 25-50% shares

Company previous names

Wren Therapeutics April 12, 2023

Company filings

Filing category
Accounts Address Capital Change of name Confirmation statement Incorporation Insolvency Officers Persons with significant control Resolution
Group of companies' report and financial statements (accounts) made up to 2022/12/31
filed on: 17th, October 2023
Free Download (34 pages)

Company search